Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Trent

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Cancer Research|March 17, 2011
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- LetterAmaury G Dumont, David G Reynoso, Jonathan C Trent
Current Oncology Reports|June 26, 2007
Sarcoma molecular testing: diagnosis and prognosisAlexander J F Lazar, Jonathan C Trent, Dina Lev
Chinese Journal of Cancer|May 30, 2012
The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancerAmaury G Dumont, Sarah N Dumont, Jonathan C Trent
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue SarcomaElizabeth H Baldini, Axel Le Cesne, Jonathan C Trent
Clinical Advances in Hematology & Oncology : H&O|January 26, 2010
Drug plasma monitoring in CML and GIST: A case-based discussionMerrill J Egorin, Michael J Mauro, Jonathan C Trent
Expert Opinion on Pharmacotherapy|February 16, 2005
Imatinib mesylate in the treatment of gastrointestinal stromal tumourDejka M Steinert, John C McAuliffe, Jonathan C Trent
Future Oncology (London, England)|November 29, 2007
Molecular approaches to resolve diagnostic dilemmas: the case of gastrointestinal stromal tumor and leiomyosarcomaJonathan C Trent, Alexander J F Lazar, Wei Zhang
Current Opinion in Oncology|May 14, 2013
Pazopanib in sarcomas: expanding the PALETTEBreelyn A Wilky, Christian F Meyer, Jonathan C Trent
Expert Review of Anticancer Therapy|March 20, 2020
Progress in determining response to treatment in gastrointestinal stromal tumorJunaid Arshad, Jibran Ahmed, Ty Subhawong, et al.
International Journal of Surgical Pathology|May 3, 2011
Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variantJoshua Anspach Hanson, Jonathan C Trent, Dan Yang, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Cancer Research|March 17, 2011
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers -- LetterAmaury G Dumont, David G Reynoso, Jonathan C Trent
Current Oncology Reports|June 26, 2007
Sarcoma molecular testing: diagnosis and prognosisAlexander J F Lazar, Jonathan C Trent, Dina Lev
Chinese Journal of Cancer|May 30, 2012
The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancerAmaury G Dumont, Sarah N Dumont, Jonathan C Trent
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Neoadjuvant Chemotherapy, Concurrent Chemoradiation, and Adjuvant Chemotherapy for High-Risk Extremity Soft Tissue SarcomaElizabeth H Baldini, Axel Le Cesne, Jonathan C Trent
Clinical Advances in Hematology & Oncology : H&O|January 26, 2010
Drug plasma monitoring in CML and GIST: A case-based discussionMerrill J Egorin, Michael J Mauro, Jonathan C Trent
Expert Opinion on Pharmacotherapy|February 16, 2005
Imatinib mesylate in the treatment of gastrointestinal stromal tumourDejka M Steinert, John C McAuliffe, Jonathan C Trent
Future Oncology (London, England)|November 29, 2007
Molecular approaches to resolve diagnostic dilemmas: the case of gastrointestinal stromal tumor and leiomyosarcomaJonathan C Trent, Alexander J F Lazar, Wei Zhang
Current Opinion in Oncology|May 14, 2013
Pazopanib in sarcomas: expanding the PALETTEBreelyn A Wilky, Christian F Meyer, Jonathan C Trent
Expert Review of Anticancer Therapy|March 20, 2020
Progress in determining response to treatment in gastrointestinal stromal tumorJunaid Arshad, Jibran Ahmed, Ty Subhawong, et al.
International Journal of Surgical Pathology|May 3, 2011
Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variantJoshua Anspach Hanson, Jonathan C Trent, Dan Yang, et al.
Pageof 14